H.R. 7777: Protecting America’s Medical Supply Chains Act of 2026
This bill, titled the Protecting America’s Medical Supply Chains Act of 2026, aims to amend the Defense Production Act of 1950 to enhance the supply of medical materials crucial for national defense. Here are the main components:
Securing Essential Medical Materials
- The bill states that authorities under the Defense Production Act should be utilized to ensure the availability of medical materials, emphasizing the importance of the U.S. being competitive and innovative.
- It expands the definition of essential materials to include medical materials such as drugs, devices, and biological products that are necessary for diagnosing, treating, or preventing diseases relevant to national defense.
Strategy on Securing Supply Chains
- Within 180 days of the bill's enactment, the President must create and submit a strategy for securing the supply of medical materials.
- The strategy must include:
- A detailed plan leveraging existing laws to safeguard the supply of medical materials critical for national defense.
- An analysis identifying vulnerabilities in current supply chains.
- Measures to diversify these supply chains as needed.
- A discussion about the anticipated impacts on the production and distribution of medical products.
- A timeline to ensure essential components are not solely controlled by foreign governments, which could pose a national security risk.
- Efforts to maintain U.S. competitiveness in global markets and foster cooperation with allies.
- The President must also submit annual progress reports to Congress until September 30, 2029, detailing the implementation of the strategy.
Investment in Supply Chain Security
- The bill establishes that the President can make payments to entities that are crucial for increasing supply chain security, provided Congress is notified in advance.
- Eligible entities must be registered in the U.S. and produce critical components or products necessary for supply chain security.
Regulatory Framework
- The President is tasked with creating regulations that define "supply chain" and "supply chain activities" within 90 days of the bill's enactment.
- The definitions should cover all aspects involved in delivering products or services to the government.
Focus on Domestic Capability
- The bill emphasizes strengthening the domestic capability to produce essential medical materials, enhancing the resilience of the nation’s medical supply chains.
Overall Goals
- This legislation aims to bolster the U.S. medical supply chains by ensuring essential materials are available, reducing dependency on foreign sources, and improving the overall security of the supply chains for medical materials vital to the nation's defense.
Relevant Companies
- None found
This is an AI-generated summary of the bill text. There may be mistakes.
Show More
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Mar. 03, 2026 | Introduced in House |
| Mar. 03, 2026 | Referred to the House Committee on Financial Services. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
Potentially Relevant Congressional Stock Trades
No relevant congressional stock trades found.